Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
P
304840
vs
K
KOSPI 200
Over the past 12 months, PeopleBio Inc has underperformed KOSPI 200, delivering a return of -64% compared to KOSPI 200's +119% growth.
Stocks Performance
304840 vs KOSPI 200
Performance Gap
304840 vs KOSPI 200
Performance By Year
304840 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
PeopleBio Inc
Glance View
PeopleBio Inc. is a South Korean biotechnology company that develops blood-based diagnostic tools and biomarker products. Its core work is finding disease signals in blood, with a strong focus on neurodegenerative conditions such as Alzheimer’s disease. The company turns that science into laboratory tests and related research products that can help doctors and researchers detect or study disease earlier and more directly than with traditional methods. The company sells its products and services mainly to hospitals, research institutions, and drug developers. It makes money by selling diagnostic kits, laboratory testing services, and research tools, and it can also earn income through collaborative projects and technology-based agreements. That puts PeopleBio in the middle of the life-sciences value chain: it is not a drug maker, but a developer of the testing tools and biomarker methods that others use to diagnose disease and advance new treatments. What makes the business distinct is its focus on blood biomarkers, especially for hard-to-detect brain diseases. Instead of relying only on imaging or invasive procedures, PeopleBio works on tests that use a simple blood sample to reveal disease-related proteins and other markers. That gives the company a specialized role in diagnostics, where the value comes from turning complex biology into practical tests that can be used in clinics and research labs.